Currently, four ways of regulating BCL11A in lung cancer are known: by miRNA—miR-30a (silencing), amplification (activation), long non-coding RNA—DSCAM-AS1 (activation) and SOX2 (regulation at the transcription level) [8,27,29]. Here, BCL11A is linked to lung carcinoma.